Source: Business Wire

Sean A. MacDonald is now CEO at Domain Therapeutics

Read full article »

Domain Therapeutics's Competitors | Domain Therapeutics's News | Domain Therapeutics's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

CEO

Sean A. MacDonald

CEO Approval Rating

90/100

Domain Therapeutics is a France-based biopharmaceutical company that researches and develops GPCR-mediated immunotherapies for the treatment of cancer.